Aligos Therapeutics, Inc. (ALGS)

Last Year

16-May-23 -- 15-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

8

0

3

+1

0

+2

0

+3

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Oct-23 4:13 PM View:	25-Oct-23 Grant $138.56K	Scopa James Paul Director		Aligos Therapeutics, Inc. - ALGS	100% 0 to 183.08K	0	0	--	--	Show Txns Hide Txns

27-Oct-23 4:14 PM View:	25-Oct-23 Grant $461.86K	Blatt Lawrence Chief Executive Officer Director		Aligos Therapeutics, Inc. - ALGS	40% 1.51M to 2.12M	0	0	--	--	Show Txns Hide Txns

27-Oct-23 4:15 PM View:	25-Oct-23 Private Purchase $6.00M	Nuechterlein Carole Director		Aligos Therapeutics, Inc. - ALGS	257% 3.09M to 11.03M	0	0	--	--	Show Txns Hide Txns